These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27643868)

  • 1. Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab.
    Bhatt V; Shune L; Lauer E; Lubin M; Devlin SM; Scaradavou A; Parameswaran R; Perales MA; Ponce DM; Mantha S; Kernan NA; Barker JN
    Bone Marrow Transplant; 2016 Dec; 51(12):1579-1583. PubMed ID: 27643868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience.
    Sanz J; Arango M; Carpio N; Montesinos P; Moscardó F; Martín G; López F; Jarque I; Lorenzo I; de la Rubia J; Solves P; Boluda B; Salazar C; Cañigral C; Sanz MA; Sanz GF
    Bone Marrow Transplant; 2014 Aug; 49(8):1084-8. PubMed ID: 24887383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
    Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
    Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel immunomodulatory treatment involving mycophenolate mofetil and corticosteroids for pediatric autoimmune cytopenias.
    Panigrahi A; Clark A; Myers J; Raj A
    Pediatr Blood Cancer; 2017 Feb; 64(2):287-293. PubMed ID: 27615037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
    Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H.
    Chao MM; Levine JE; Ferrara JL; Cooling L; Cooke KR; Hutchinson RJ; Yanik GA
    Pediatr Blood Cancer; 2008 Apr; 50(4):917-9. PubMed ID: 17417790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura in pediatric solid organ transplant recipients, report of five cases and review of the literature.
    Miloh T; Arnon R; Roman E; Hurlet A; Kerkar N; Wistinghausen B
    Pediatr Transplant; 2011 Dec; 15(8):870-8. PubMed ID: 22112003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
    Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
    Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.
    Oved JH; Lee CSY; Bussel JB
    J Pediatr; 2017 Dec; 191():225-231. PubMed ID: 29173312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab.
    Radhi M; Rumelhart S; Tatman D; Goldman F
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):125-7. PubMed ID: 17279011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency.
    Ramyar A; Aghamohammadi A; Moazzami K; Rezaei N; Yeganeh M; Cheraghi T; Pouladi N; Heydari G; Abolhassani H; Amirzargar AA; Parvaneh N; Moin M
    Iran J Allergy Asthma Immunol; 2008 Sep; 7(3):169-75. PubMed ID: 18780952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation.
    Daikeler T; Labopin M; Ruggeri A; Crotta A; Abinun M; Hussein AA; Carlson K; Cornillon J; Diez-Martin JL; Gandemer V; Faraci M; Lindemans C; O'Meara A; Mialou V; Renard M; Sedlacek P; Sirvent A; Socié G; Sora F; Varotto S; Sanz J; Voswinkel J; Vora A; Yesilipek MA; Herr AL; Gluckman E; Farge D; Rocha V
    Blood; 2013 Feb; 121(6):1059-64. PubMed ID: 23247725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary immunodeficiencies presenting with autoimmune cytopenias in adults].
    Sève P; Broussolle C; Pavic M
    Rev Med Interne; 2013 Mar; 34(3):148-53. PubMed ID: 22703729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux.
    Deshayes S; Khellaf M; Zarour A; Layese R; Fain O; Terriou L; Viallard JF; Cheze S; Graveleau J; Slama B; Audia S; Cliquennois M; Ebbo M; Le Guenno G; Salles G; Bonmati C; Teillet F; Galicier L; Lambotte O; Hot A; Lefrère F; Mahévas M; Canoui-Poitrine F; Michel M; Godeau B
    Am J Hematol; 2019 Dec; 94(12):1314-1324. PubMed ID: 31489694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded utilization of rituximab in paediatric cardiac transplant patients.
    Kiskaddon AL; Landmesser K; Carapellucci J; Wisotzkey B; Asante-Korang A
    J Clin Pharm Ther; 2021 Jun; 46(3):762-766. PubMed ID: 33393702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab.
    Solomon SR; Sizemore CA; Ridgeway M; Zhang X; Smith J; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1576-82. PubMed ID: 25985915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.